HALO logo
halo search icon
Algernon Pharmaceuticals Inc. Class A
Algernon Pharmaceuticals Inc. Class A
AGN · CNQ

Algernon Pharmaceuticals Inc. Class A

CA$0.38

Price Arrow-0.015 (-3.75%)
19/05/2026 12:00:00 AM
All-Companies
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Algernon Pharmaceuticals Inc. Class A Overview

AGN Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About AGN

icon

Website

Algernon Pharmaceuticals Inc. Class A

icon

Telephone

icon

Address

Description

Grey Matters Health, Inc. is a drug re-purposing company that investigates safe, already approved drugs, including naturally occurring compounds, for new disease applications, moving them into new human trials, developing new formulations and seeking new regulatory approvals in global markets. It specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off label prescription writing. The company was founded on January 22, 2015 and is headquartered in Vancouver, Canada.

AGN Price Chart

Key Stats

Market Cap

CA$2.09M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.04 - 0.55

Trade Value (12mth)

US$632.00

1 week

-3.75%

1 month

-22.22%

YTD

541.67%

1 year

352.94%

All time high

11.90

Key Fundamentals

EPS 3 yr Growth

-92.70%

EBITDA Margin

0.00%

Operating Cashflow

-$1m

Free Cash Flow Return

-47.60%

ROIC

-70.60%

Interest Coverage

0.00

Quick Ratio

0.30

Other Data

Shares Outstanding (Fully Diluted)

5m

HALO Sector

Healthcare

Next Company Report Date

18-Dec-26

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

AGN Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-3.32-0.18-0.42locklocklock
EPS (Fully Diluted)
$locklocklocklock-3.32-0.18-0.42locklocklock
Growth
%locklocklocklock42.194.4-126.1locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Algernon Pharmaceuticals Inc. Class A (AGN:CNQ)?
Halo FAQ
The current share price of Algernon Pharmaceuticals Inc. Class A (AGN:CNQ) is CAD$0.38.
What is the 52-week high share price for Algernon Pharmaceuticals Inc. Class A (AGN:CNQ)?
Halo FAQ
The 52-week high share price for Algernon Pharmaceuticals Inc. Class A (AGN:CNQ) is CAD$0.55.
What is the 52-week low share price for Algernon Pharmaceuticals Inc. Class A (AGN:CNQ)?
Halo FAQ
The 52-week low share price for Algernon Pharmaceuticals Inc. Class A (AGN:CNQ) is CAD$0.04.
What is the dividend yield for Algernon Pharmaceuticals Inc. Class A (AGN:CNQ)?
Halo FAQ
Algernon Pharmaceuticals Inc. Class A (AGN:CNQ) does not pay a dividend.
What was Algernon Pharmaceuticals Inc. Class A (AGN:CNQ) last dividend payment?
Halo FAQ
Algernon Pharmaceuticals Inc. Class A (AGN:CNQ) does not pay a dividend.
What is the franking level for Algernon Pharmaceuticals Inc. Class A (AGN:CNQ)?
Halo FAQ
Algernon Pharmaceuticals Inc. Class A (AGN:CNQ) has a franking level of 0.00%.
In which sector is Algernon Pharmaceuticals Inc. Class A (AGN:CNQ) classified?
Halo FAQ
Algernon Pharmaceuticals Inc. Class A (AGN:CNQ) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.